Existing antiviral options against SARS-CoV-2 replication in COVID-19 patients

COVID-19 caused by SARS-CoV-2, is an international concern. This infection requires urgent efforts to develop new antiviral compounds. To date, no specific drug in controlling this disease has been identified. Developing the new treatment is usually time consuming, therefore using the repurposing br...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghanbari, Reza, Teimoori, Ali, Sadeghi, Anahita, Mohamadkhani, Ashraf, Rezasoltani, Sama, Asadi, Ebrahim, Jouyban, Abolghasem, Sumner, Susan CJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789744/
https://www.ncbi.nlm.nih.gov/pubmed/33404263
http://dx.doi.org/10.2217/fmb-2020-0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789744/
https://www.ncbi.nlm.nih.gov/pubmed/33404263
http://dx.doi.org/10.2217/fmb-2020-0120

Ejemplares similares